维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Ruottinen H"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Cognitive impairment and the brain dopaminergic system in Parkinson disease: 18F-fluorodopa positron emission tomographic study 显示文摘	Rinne J O Portin R Ruottinen H	2000	Arch Neurol2000，57，4：	1
2	Incresed density of dopamine D2 receptors in the putamen,but not in the caudate nucleus in early Parkinson's disease:a PET study with 11 C-Raclopride显示文摘	Rinno J O Laihinen A Ruottinen H	1995	Neurol Sci1995，132，：	1
3	Striatal uptake of a novel PET ligand, beta-CET, is reduced in early Parkinson's disease显示文摘	Rinne JO Bergman J Ruottinen H	1999	Synapse1999，31，：	1
4	Clinical MRI for iron detection in Parkinson's disease 显示文摘	Rossi M Ruottinen H Soimakallio S	2013	Clin Imaging2013，37，：	1
5	Clinical MRI for iron detec- tion in Parkinson's disease显示文摘	Rossi M Ruottinen H Soimakallio S	2013	Clinical Imaging2013，37，4：	1
6	Brain iron deposition and sequence characteristics in Parkinsonism: comparison of SWI, T(2)* maps, T(2)-weighted-, and FLAIR-SPACE显示文摘	Rossi M Ruottinen H Elovaara I	2010	Invest Radiol2010，45，：	1
7	Cognitive impairment and the brain dopaminergie system in Parkinson disease: fluorodopa positron emission tomographie study 显示文摘	Rinne JO Portin R Ruottinen H	2000	Archives of neurology2000，57，4：	1
8	Dietary fiber does not displace energy but is associated with decreased serum cholesterol concentrations in healthy children显示文摘	RUOTTINEN S LAGSTROM H K NⅡNIKOSKI H	2010	American Journal of Clinical Nutrition2010，91，3：	1
9	Risk for Parkinson's disease:twin studies for the detection of asymptomatic subjects using 6-fluorodopa PET显示文摘	Ruottinen H Rinne JO	2000	J Neurol2000，247，2：	1
10	Cognitive impairment and the brain dopaminergic system in Parkinson disease:^18F fluorodopa positron emission tomographic study显示文摘	Rinne JO Portin R Ruottinen H	2000	Arch Neurol2000，57，4：	1
11	Striatal Uptake of the Dopamine Reuptake Ligand beta-CFT is Reduced in Alzheimer's Disease Assessed by Positron Emission Tomography显示文摘	Rinne JO Sahlberg N Ruottinen H	1998	Neurology1998，50，：	1
12	PETshows that striatal dopamine D1 and D2 receptors are differently affected in AD显示文摘	Kemppainen N Ruottinen H Nagren K	2000	Neurology2000，55，2：	1
13	Cognitive impairment and the brain dopaminergic system in Parkinson' s disease: fluorodopa positron emission tomographic study显示文摘	Rinne JO Portin R Ruottinen H	2000	Arch Neurol2000，57，4：	1
14	Usefulness of a dopamine transporter PET ligand beta-CFT in assessing disability in Parkinson's disease显示文摘	Rinne JO Ruottinen H Bergman J	1999	J Neural Neurosurg Psychiatry1999，67，6：	1
15	Increased density of dopamine D2 receptors in the putamen,but not in the caudate nucleus in the early Parkinson's disease:a PET study with raclopride 显示文摘	Laihinen A Ruottinen H	1995	J Neurol Sci1995，132，2：	1
16	Cognitive impairment and the brain dopaminergic system in Parkinson disease : l 8F-fluorodopa positron emission tomographic study 显示文摘	Rinne JO Portin R Ruottinen H	2000	Arch Neurol2000，57，4：	1
17	Striatal uptake of a novel PET ligand,beta- CFT,is reduced in early Parkinson's disease显示文摘	Bergman J Ruottinen H	1999	Synapse1999，31，2：	1
18	Cognitive impairment and the brain dopaminergie system in Parkinson disease: fluorodopa positron emission tomographie study显示文摘	Rinne JO Portin R Ruottinen H	2000	Arch Neu- rol2000，57，4：	1
19	Usefulness of a dopamine transporter PET ligand (18)Fβ-CFT in assessing disability in Parkinson's disease显示文摘	Rinne JO Ruottinen H Bergman J	1999	J Neurol Neurosurg Psychiatry1999，67，：	1
20	Upregulation of putaminal Dz receptors in early Parkinson's disease: A comparative PET study with raclopride and N-methylspiperoni 显示文摘	Kaasinen V Ruottinen H M Nagren K	2000	Journal of Nuclear Medicine2000，41，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示